Published in Pharmaceutics on July 07, 2016
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol (2006) 1.62
Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect Dis Clin North Am (2003) 1.39
Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm (2008) 1.12
Skin penetration enhancers. Int J Pharm (2013) 1.09
Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol (2001) 1.08
Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs (2009) 1.08
Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharm Res (2008) 1.04
Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol (2009) 1.03
Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Mycoses (2011) 0.98
Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products. J Am Acad Dermatol (2003) 0.98
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Chemotherapy (2004) 0.97
Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol (1993) 0.96
Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery. Pharm Res (2005) 0.95
Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A (1997) 0.95
Sertaconazole in the treatment of mycoses: from dermatology to gynecology. Int J Gynaecol Obstet (2000) 0.92
Dermatopharmacokinetic prediction of topical drug bioavailability in vivo. J Invest Dermatol (2006) 0.92
In vitro skin irritation testing: Improving the sensitivity of the EpiDerm skin irritation test protocol. Altern Lab Anim (2009) 0.88
Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. J Drugs Dermatol (2006) 0.87
Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. Arzneimittelforschung (2005) 0.87
Cutaneous bioassay of salicylic acid as a keratolytic. Int J Pharm (2005) 0.87
In vitro antifungal activity of sertaconazole. Arzneimittelforschung (1992) 0.84
Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man. Pharm Res (2001) 0.84
A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology (2002) 0.83
Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections. Diagn Microbiol Infect Dis (2006) 0.83
Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res (1999) 0.83
Dermatopharmacokinetics of betamethasone 17-valerate: influence of formulation viscosity and skin surface cleaning procedure. Eur J Pharm Biopharm (2008) 0.83
An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis. J Drugs Dermatol (2011) 0.82
Treatment of interdigital tinea pedis: once-daily therapy with sertaconazole nitrate. J Drugs Dermatol (2011) 0.81
Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models. J Pharm Sci (2003) 0.81
Determining dermal absorption parameters in vivo from tape strip data. Pharm Res (2002) 0.80
Characteristic differences in barrier and hygroscopic properties between normal and cosmetic dry skin. I. Enhanced barrier analysis with sequential tape-stripping. Int J Cosmet Sci (2014) 0.79
Dermatologic infections in cancer patients. Cancer Treat Res (2014) 0.78
An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. J Vis Exp (2009) 0.78
Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol (1992) 0.78
In vitro vs. in vivo tape stripping: validation of the porcine ear model and penetration assessment of novel sucrose stearate emulsions. Eur J Pharm Biopharm (2011) 0.78
In vivo barrier challenge and initial recovery in human facial skin. Skin Res Technol (2012) 0.78
Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream. Ann Parasitol (2013) 0.78
In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream. Drug Dev Ind Pharm (2012) 0.77
Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis. Expert Rev Anti Infect Ther (2013) 0.76
Inhibition of ergosterol synthesis by sertaconazole in Candida albicans. Arzneimittelforschung (1992) 0.76
Lateral spreading of topically applied UV filter substances investigated by tape stripping. Skin Pharmacol Physiol (2004) 0.76
Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans. Pharm Res (2002) 0.76
Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate. Cutis (2008) 0.76
Correlation between stratum corneum/water-partition coefficient and amounts of flufenamic acid penetrated into the stratum corneum. J Pharm Sci (2002) 0.76
Mathematical model to predict skin concentration after topical application of drugs. Pharmaceutics (2013) 0.76